Eli Lilly & Co. Files Q3 2024 10-Q Report
Ticker: LLY · Form: 10-Q · Filed: 2024-10-30T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Lilly's Q3 10-Q is in! Check financials for Q3 2024.
AI Summary
Eli Lilly and Company (LLY) filed its 10-Q for the period ending September 30, 2024. The company reported its financial performance and provided updates on its business operations. Key financial details and operational highlights are presented in this filing.
Why It Matters
This filing provides investors and analysts with crucial financial data and operational insights into Eli Lilly's performance during the third quarter of 2024, impacting investment decisions.
Risk Assessment
Risk Level: medium — Quarterly reports can reveal shifts in financial health, product performance, or regulatory challenges that may impact stock price.
Key Players & Entities
- ELI LILLY & Co (company) — Filer of the 10-Q report
- 0000059478 (company) — Central Index Key for Eli Lilly & Co.
- 20240930 (date) — End of the reporting period for the 10-Q
- 20241030 (date) — Date the 10-Q was filed
- Indianapolis, IN (location) — Company's business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on October 30, 2024.
What is Eli Lilly & Co.'s Central Index Key (CIK)?
Eli Lilly & Co.'s Central Index Key is 0000059478.
Where is Eli Lilly & Co. headquartered?
Eli Lilly & Co.'s business and mailing address is in Indianapolis, IN.
What is the Standard Industrial Classification (SIC) code for Eli Lilly & Co.?
The Standard Industrial Classification code for Eli Lilly & Co. is 2834, Pharmaceutical Preparations.
From the Filing
0000059478-24-000245.txt : 20241030 0000059478-24-000245.hdr.sgml : 20241030 20241030115410 ACCESSION NUMBER: 0000059478-24-000245 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 75 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241030 DATE AS OF CHANGE: 20241030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 241408501 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 10-Q 1 lly-20240930.htm 10-Q lly-20240930 FALSE 2024 Q3 0000059478 12/31 TRUE FALSE http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent 210 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:EUR iso4217:JPY iso4217:GBP iso4217:CNY lly:patent iso4217:BRL 0000059478 2024-01-01 2024-09-30 0000059478 us-gaap:CommonClassAMember 2024-01-01 2024-09-30 0000059478 lly:A718NotesDueJune12025Member 2024-01-01 2024-09-30 0000059478 lly:A1.625NotesDueJune22026Member 2024-01-01 2024-09-30 0000059478 lly:A2.125NotesDueJune32030Member 2024-01-01 2024-09-30 0000059478 lly:A625NotesDue2031Member 2024-01-01 2024-09-30 0000059478 lly:A500NotesDue2033Member 2024-01-01 2024-09-30 0000059478 lly:A6.77NotesDueJanuary12036Member 2024-01-01 2024-09-30 0000059478 lly:A1625NotesDue2043Member 2024-01-01 2024-09-30 0000059478 lly:A1700NotesDue2049Member 2024-01-01 2024-09-30 0000059478 lly:A1125NotesDue2051Member 2024-01-01 2024-09-30 0000059478 lly:A1375NotesDue2061Member 2024-01-01 2024-09-30 0000059478 2024-10-25 0000059478 2024-07-01 2024-09-30 0000059478 2023-07-01 2023-09-30 0000059478 2023-01-01 2023-09-30 0000059478 2024-09-30 0000059478 2023-12-31 0000059478 us-gaap:CommonStockMember 2023-06-30 0000059478 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000059478 us-gaap:RetainedEarningsMember 2023-06-30 0000059478 us-gaap:TrustForBenefitOfEmployeesMember 2023-06-30 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000059478 us-gaap:TreasuryStockCommonMember 2023-06-30 0000059478 us-gaap:NoncontrollingInterestMember 2023-06-30 0000059478 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000059478 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000059478 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000059478 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000059478 us-gaap:CommonStockMember 2023-09-30 0000059478 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000059478 us-gaap:RetainedEarningsMember 2023-09-30 0000059478 us-gaap:TrustForBenefitOfEmployeesMember 2023-09-30 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000059478 us-gaap:TreasuryStockCommonMember 2023-09-30 0000059478 us-gaap:NoncontrollingInterestMember 2023-09-30 0000059478 us-gaap:CommonStockMember 2024-06-30 0000059478 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000059478 us-gaap:RetainedEarningsMember 2024-06-30 0000059478 us-gaap:TrustForBenefitOfEmployeesMember 2024-06-30 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000059478 us-gaap:TreasuryStockCommonMember 2024-06-30 0000059478 us-gaap:NoncontrollingInterestMember 2024-06-30 0000059478 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000059478 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000059478 us-gaap:CommonStockMember 2024-07-01 2024-09-